Literature DB >> 23818043

The Cag pathogenicity island and interaction between TLR2/NOD2 and NLRP3 regulate IL-1β production in Helicobacter pylori infected dendritic cells.

Dong-Jae Kim1, Jong-Hwan Park, Luigi Franchi, Steffen Backert, Gabriel Núñez.   

Abstract

Helicobacter pylori colonization of the stomach affects about half of the world population and is associated with the development of gastritis, ulcers, and cancer. Polymorphisms in the IL1B gene are linked to an increased risk of H. pylori associated cancer, but the bacterial and host factors that regulate interleukin (IL)-1β production in response to H. pylori infection remain unknown. Using murine BM-derived DCs, we show that the bacterial virulence factors cytotoxin-associated genes pathogenicity island and CagL, but not vacuolating cytotoxin A or CagA, regulate the induction of pro-IL-1β and the production of mature IL-1β in response to H. pylori infection. We further show that the host receptors, Toll-like receptor 2 (TLR2) and nucleotide-binding oligomerization domain 2 (NOD2), but not NOD1, are required for induction of pro-IL-1β and NOD-like receptor pyrin domain containing 3 (NLRP3) in H. pylori infected DCs. In contrast, NLRP3 and the adaptor ASC were essential for the activation of caspase-1, processing of pro-IL-1β into IL-1β, and IL-1β secretion. Finally, we show that mice deficient in caspase-1, IL-1β, and IL-1 receptor, but not NLRP3, are impaired in the clearance of CagA-positive H. pylori from the stomach when compared with WT mice. These studies identify bacterial cag pathogenicity island and the cooperative interaction among host innate receptors TLR2, NOD2, and NLRP3 as important regulators of IL-1β production in H. pylori infected DCs.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Helicobacter pylori; IL-1β; Inflammasome; NLRP3; NOD2

Mesh:

Substances:

Year:  2013        PMID: 23818043      PMCID: PMC3797179          DOI: 10.1002/eji.201243281

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

Review 1.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

Review 2.  Helicobacter pylori and gastrointestinal tract adenocarcinomas.

Authors:  Richard M Peek; Martin J Blaser
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

3.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

Review 4.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

5.  Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island.

Authors:  Jérôme Viala; Catherine Chaput; Ivo G Boneca; Ana Cardona; Stephen E Girardin; Anthony P Moran; Rafika Athman; Sylvie Mémet; Michel R Huerre; Anthony J Coyle; Peter S DiStefano; Philippe J Sansonetti; Agnès Labigne; John Bertin; Dana J Philpott; Richard L Ferrero
Journal:  Nat Immunol       Date:  2004-10-17       Impact factor: 25.606

6.  Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.

Authors:  Naohiro Inohara; Yasunori Ogura; Ana Fontalba; Olga Gutierrez; Fernando Pons; Javier Crespo; Koichi Fukase; Seiichi Inamura; Shoichi Kusumoto; Masahito Hashimoto; Simon J Foster; Anthony P Moran; Jose L Fernandez-Luna; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2003-01-04       Impact factor: 5.157

7.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

8.  An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid.

Authors:  Mathias Chamaillard; Masahito Hashimoto; Yasuo Horie; Junya Masumoto; Su Qiu; Lisa Saab; Yasunori Ogura; Akiko Kawasaki; Koichi Fukase; Shoichi Kusumoto; Miguel A Valvano; Simon J Foster; Tak W Mak; Gabriel Nuñez; Naohiro Inohara
Journal:  Nat Immunol       Date:  2003-06-06       Impact factor: 25.606

9.  Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan.

Authors:  Stephen E Girardin; Ivo G Boneca; Leticia A M Carneiro; Aude Antignac; Muguette Jéhanno; Jérôme Viala; Karsten Tedin; Muhamed-Kheir Taha; Agnes Labigne; Ulrich Zähringer; Anthony J Coyle; Peter S DiStefano; John Bertin; Philippe J Sansonetti; Dana J Philpott
Journal:  Science       Date:  2003-06-06       Impact factor: 47.728

10.  Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia.

Authors:  James G Fox; Timothy C Wang; Arlin B Rogers; Theofilos Poutahidis; Zhongming Ge; Nancy Taylor; Charles A Dangler; Dawn A Israel; Uma Krishna; Kristen Gaus; Richard M Peek
Journal:  Gastroenterology       Date:  2003-06       Impact factor: 22.682

View more
  49 in total

1.  Absent in melanoma 2 (AIM2) expressed in human dental pulp mediates IL-1β secretion in response to cytoplasmic DNA.

Authors:  Shuheng Huang; Zhi Song; Lan Jiang; Lingling Chen; Runfu Wang; Wei Qin; Pengcheng Liu; Zhengmei Lin
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

2.  TLR4, NOD1 and NOD2 mediate immune recognition of putative newly identified periodontal pathogens.

Authors:  Julie Marchesan; Yizu Jiao; Riley A Schaff; Jie Hao; Thiago Morelli; Janet S Kinney; Elizabeth Gerow; Rachel Sheridan; Vinicius Rodrigues; Bruce J Paster; Naohiro Inohara; William V Giannobile
Journal:  Mol Oral Microbiol       Date:  2015-09-10       Impact factor: 3.563

3.  Helicobacter pylori controls NLRP3 expression by regulating hsa-miR-223-3p and IL-10 in cultured and primary human immune cells.

Authors:  Suneesh Kumar Pachathundikandi; Steffen Backert
Journal:  Innate Immun       Date:  2017-11-16       Impact factor: 2.680

Review 4.  Evasion and interference: intracellular pathogens modulate caspase-dependent inflammatory responses.

Authors:  Mary K Stewart; Brad T Cookson
Journal:  Nat Rev Microbiol       Date:  2016-05-13       Impact factor: 60.633

Review 5.  Helicobacter pylori activates the TLR2/NLRP3/caspase-1/IL-18 axis to induce regulatory T-cells, establish persistent infection and promote tolerance to allergens.

Authors:  Katrin N Koch; Anne Müller
Journal:  Gut Microbes       Date:  2015

6.  Association between receptor interacting serine/threonine kinase 2 polymorphisms and gastric cancer susceptibility.

Authors:  Masafumi Ota; Tomomitsu Tahara; Toshimi Otsuka; Wu Jing; Tomoe Nomura; Ranji Hayashi; Takeo Shimasaki; Masakatsu Nakamura; Tomoyuki Shibata; Tomiyasu Arisawa
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

Review 7.  Role of Toll-like receptors in Helicobacter pylori infection and immunity.

Authors:  Sinéad M Smith
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 8.  Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells.

Authors:  Suneesh Kumar Pachathundikandi; Nicole Tegtmeyer; Steffen Backert
Journal:  Gut Microbes       Date:  2013-11-06

Review 9.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

10.  Helicobacter urease-induced activation of the TLR2/NLRP3/IL-18 axis protects against asthma.

Authors:  Katrin N Koch; Mara L Hartung; Sabine Urban; Andreas Kyburz; Anna S Bahlmann; Judith Lind; Steffen Backert; Christian Taube; Anne Müller
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.